Cargando…

Giemsa‐negative chromosome bands preferentially recombine in cancer‐associated translocations and gene fusions

Chromosome abnormalities, in particular translocations, and gene fusions are hallmarks of neoplasia. Although both have been recognized as important drivers of cancer for decades, our knowledge of the characterizing features of the cytobands involved in recombinations is poorly understood. The prese...

Descripción completa

Detalles Bibliográficos
Autores principales: Mandahl, Nils, Mitelman, Felix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092824/
https://www.ncbi.nlm.nih.gov/pubmed/36116030
http://dx.doi.org/10.1002/gcc.23095
_version_ 1785023439662219264
author Mandahl, Nils
Mitelman, Felix
author_facet Mandahl, Nils
Mitelman, Felix
author_sort Mandahl, Nils
collection PubMed
description Chromosome abnormalities, in particular translocations, and gene fusions are hallmarks of neoplasia. Although both have been recognized as important drivers of cancer for decades, our knowledge of the characterizing features of the cytobands involved in recombinations is poorly understood. The present study, based on a comparative analysis of 10 442 translocation breakpoints and 30 762 gene fusions comprising 13 864 protein‐coding genes, is the most comprehensive evaluation of the interactions of cytobands participating in the formation of such rearrangements in cancer. The major conclusion is that although large G‐negative, gene‐rich bands are most frequently involved, the greatest impact was seen for staining properties. Thus, 60% of the recombinations leading to the formation of both translocations and fusion genes take place between two G‐negative bands whereas only about 10% involve two G‐positive bands. There is compelling evidence that G‐negative bands contain more genes than dark staining bands and it has previously been shown that breakpoints involved in structural chromosome rearrangements and in gene fusions preferentially affect gene‐rich bands. The present study not only corroborates these findings but in addition demonstrates that the recombination processes favor the joining of two G‐negative cytobands and that this feature may be a stronger factor than gene content. It is reasonable to assume that the formation of translocations and fusion genes in cancer cells, irrespective of whether they have a pathogenetically significant impact or not, may be mediated by some underlying mechanisms that either favor the origin or provide a selective advantage for recombinations of G‐negative cytobands.
format Online
Article
Text
id pubmed-10092824
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-100928242023-04-13 Giemsa‐negative chromosome bands preferentially recombine in cancer‐associated translocations and gene fusions Mandahl, Nils Mitelman, Felix Genes Chromosomes Cancer Research Articles Chromosome abnormalities, in particular translocations, and gene fusions are hallmarks of neoplasia. Although both have been recognized as important drivers of cancer for decades, our knowledge of the characterizing features of the cytobands involved in recombinations is poorly understood. The present study, based on a comparative analysis of 10 442 translocation breakpoints and 30 762 gene fusions comprising 13 864 protein‐coding genes, is the most comprehensive evaluation of the interactions of cytobands participating in the formation of such rearrangements in cancer. The major conclusion is that although large G‐negative, gene‐rich bands are most frequently involved, the greatest impact was seen for staining properties. Thus, 60% of the recombinations leading to the formation of both translocations and fusion genes take place between two G‐negative bands whereas only about 10% involve two G‐positive bands. There is compelling evidence that G‐negative bands contain more genes than dark staining bands and it has previously been shown that breakpoints involved in structural chromosome rearrangements and in gene fusions preferentially affect gene‐rich bands. The present study not only corroborates these findings but in addition demonstrates that the recombination processes favor the joining of two G‐negative cytobands and that this feature may be a stronger factor than gene content. It is reasonable to assume that the formation of translocations and fusion genes in cancer cells, irrespective of whether they have a pathogenetically significant impact or not, may be mediated by some underlying mechanisms that either favor the origin or provide a selective advantage for recombinations of G‐negative cytobands. John Wiley & Sons, Inc. 2022-09-30 2023-02 /pmc/articles/PMC10092824/ /pubmed/36116030 http://dx.doi.org/10.1002/gcc.23095 Text en © 2022 The Authors. Genes, Chromosomes and Cancer published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Mandahl, Nils
Mitelman, Felix
Giemsa‐negative chromosome bands preferentially recombine in cancer‐associated translocations and gene fusions
title Giemsa‐negative chromosome bands preferentially recombine in cancer‐associated translocations and gene fusions
title_full Giemsa‐negative chromosome bands preferentially recombine in cancer‐associated translocations and gene fusions
title_fullStr Giemsa‐negative chromosome bands preferentially recombine in cancer‐associated translocations and gene fusions
title_full_unstemmed Giemsa‐negative chromosome bands preferentially recombine in cancer‐associated translocations and gene fusions
title_short Giemsa‐negative chromosome bands preferentially recombine in cancer‐associated translocations and gene fusions
title_sort giemsa‐negative chromosome bands preferentially recombine in cancer‐associated translocations and gene fusions
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092824/
https://www.ncbi.nlm.nih.gov/pubmed/36116030
http://dx.doi.org/10.1002/gcc.23095
work_keys_str_mv AT mandahlnils giemsanegativechromosomebandspreferentiallyrecombineincancerassociatedtranslocationsandgenefusions
AT mitelmanfelix giemsanegativechromosomebandspreferentiallyrecombineincancerassociatedtranslocationsandgenefusions